EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Comparison of Xpert MTB/RIF Assay and the Targeted Next-Generation Sequencing for the Diagnosis of Pleural Tuberculosis: A Prospective Comparative Diagnostic Accuracy Study

Peng Wen iD, Shang Xue Wang, Xiao Man Ma, Hong Yan Chen, Zeng Xia Ma, Yun Zeng Zhang, Min Wei

Infection and Drug Resistance · 2026-05 · Volume 19 · 1-11

DOI: 10.2147/idr.s589240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-05. Verfasst von Peng Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Public Health Clinical Center Affiliated to Shandong University, Jinan, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the diagnostic performance of targeted next-generation sequencing (tNGS), a multiplex PCR-based and hybrid-capture sequencing platform targeting 198 respiratory pathogens, versus Xpert MTB/RIF in diagnosing pleural tuberculosis (TB) across diverse specimen types, given the limited sensitivity of existing assays in paucibacillary disease. Patients and Methods: Consecutive patients with suspected pleural TB were prospectively enrolled. Final diagnosis was established using a composite reference standard incorporating microbiological, histopathological, and clinical criteria. Paired sputum, pleural fluid, and pleural biopsy specimens underwent tNGS, Xpert MTB/RIF, and mycobacterial culture. Diagnostic performance metrics, including sensitivity and specificity, were calculated. A predefined paired comparison (n=105) between tNGS and Xpert MTB/RIF was performed, with agreement assessed using Cohen's kappa.

Results

In the overall cohort (N = 142), tNGS demonstrated higher sensitivity than Xpert MTB/RIF and mycobacterial culture across specimen types when evaluated against the composite reference standard, while maintaining 100% specificity in the non-TB group (n = 8). In sputum samples, tNGS achieved a sensitivity of 72.73%, significantly outperforming Xpert MTB/RIF (21.43%) and MTB culture (16.30%). In pleural fluid, tNGS sensitivity (43.64%) exceeded that of Xpert MTB/RIF (30.49%) and MTB culture (24.14%), comparable to the performance of ADA ≥40 U/L (46.22%). The paired analysis confirmed that tNGS significantly outperformed Xpert MTB/RIF in overall diagnostic yield (p < 0.01), detecting 26 positive cases missed by Xpert. Among patients with culture-negative pleural tuberculosis, tNGS detected 24/60 (40.0%) cases compared with 6/60 (10.0%) by Xpert MTB/RIF. Conclusion: tNGS provides incremental diagnostic value over conventional molecular and culture-based assays in pleural tuberculosis, particularly in paucibacillary and culture-negative disease. It increases microbiological confirmation in culture- and Xpert-negative cases and is best positioned as a complementary second-line assay within a tiered diagnostic framework, despite no assessment of downstream clinical impact.

Schlagwörter

Stichwörter der Autor:innen

Xpert MTB/RIFdiagnosispleural tuberculosistargeted next-generation sequencing

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Public Health Clinical Center Affiliated to Shandong University, Jinan, People's Republic of China.
  • Department of Thoracic Surgery, Public Health Clinical Center Affiliated to Shandong University, Jinan, People's Republic of China.

ORCID-Profile: Peng Wen

Zitieren

APA

Wen, P., Wang, S. X., Ma, X. M., Chen, H. Y., Ma, Z. X., Zhang, Y. Z., & Wei, M. (2026). Comparison of Xpert MTB/RIF Assay and the Targeted Next-Generation Sequencing for the Diagnosis of Pleural Tuberculosis: A Prospective Comparative Diagnostic Accuracy Study. Infection and Drug Resistance, Volume 19, 1-11. https://doi.org/10.2147/idr.s589240

Vancouver

Wen P, Wang SX, Ma XM, Chen HY, Ma ZX, Zhang YZ, et al. Comparison of Xpert MTB/RIF Assay and the Targeted Next-Generation Sequencing for the Diagnosis of Pleural Tuberculosis: A Prospective Comparative Diagnostic Accuracy Study. Infection and Drug Resistance. 2026;Volume 19:1-11. doi:10.2147/idr.s589240

BibTeX
@article{Wen2026,
  author = {Wen, Peng and Wang, Shang Xue and Ma, Xiao Man and Chen, Hong Yan and Ma, Zeng Xia and Zhang, Yun Zeng and Wei, Min},
  title = {Comparison of Xpert MTB/RIF Assay and the Targeted Next-Generation Sequencing for the Diagnosis of Pleural Tuberculosis: A Prospective Comparative Diagnostic Accuracy Study},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--11},
  doi = {10.2147/idr.s589240}
}
Kostenlos starten →